Clinical Trial Update: Evaluating Subjective Well-being in Schizophrenic Patients Treated With quetiapineXR® and Other Atypical Antipsychotics

View source ↗

Summary

AstraZeneca-sponsored clinical trial update reports on subjective well-being in schizophrenia patients treated with quetiapine XR and other atypical antipsychot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Quetiapine XR (quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia | Status: COMPLETED